Rho Kinase Inhibition
Rho Kinase Inhibition - Related Videos
08:00
Enhancing the Engraftment of Human Induced Pluripotent Stem Cell-derived Cardiomyocytes via a Transient Inhibition of Rho Kinase Activity
0 Views •
Cited by 8 •
2019
In this protocol, we demonstrate and elaborate on how to use human induced pluripotent stem cells for cardiomyocyte differentiation and purification, and further, on how to improve its transplantation efficiency with Rho-associated protein kinase inhibitor pretreatment in a mouse myocardial infarction model.
01:24
Small GTPases - Ras and Rho
0 Views •
2023
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides. Three regulatory proteins control their activity: Guanine nucleotide exchange factors or GEF, GTPase-activating proteins or GAPs, and Guanine nucleotide-dissociation inhibitors or GDIs. The GEF activates the GTPase by exchanging the bound-GDP with GTP. The GTPases’...
02:54
Protein Kinases and Phosphatases
0 Views •
2020
Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven. Protein kinases Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
01:21
Cell Polarization by Rho Proteins
0 Views •
2023
Cell polarity is the asymmetric distribution of cellular and membrane components, making one side of the cell different from the other. This polarity is essential to many processes such as embryogenesis, axon migration, glucose transport across epithelial cells, and directional cell migration. A migrating cell responds to intracellular or extracellular signals via molecular cascades that reorganize the actin cytoskeleton to establish this polarity. In these cells, the Rho family proteins Cdc42,...
06:09
Assaying the Kinase Activity of LRRK2 in vitro
0 Views •
Cited by 3 •
2012
Leucine Rich Repeat Kinase 2 is a large multidomain kinase, mutations in which are the most common genetic cause of Parkinson's disease. Analysis of the kinase activity of this protein has proven to be a crucial tool in understanding the biology and dysfunction of this protein. In this paper, in vitro assaying of the kinase activity of LRRK2 and a selection of its mutants is described, providing an experimental system to examine phosphorylation of putative substrates and potential dysfunction...
FAQs
At the biochemical level, inhibition interrupts two ROCK-dependent phosphorylation routes. Reduced phosphorylation of myosin light chain phosphatase can lower actomyosin tension, while reduced LIM kinase phosphorylation changes actin dynamics. Considering both branches is important because the resulting phenotype reflects coordinated changes in contractility and filament organization rather than a single alteration in the cytoskeleton.
Because RhoA signaling can influence several aspects of cell behavior through ROCK, inhibition provides a functional link between pathway activity and phenotype. Changes in actomyosin tension, stress-fiber formation, or actin dynamics can help interpret how signaling contributes to cell shape, adhesion, and movement. This makes the approach valuable for connecting molecular events with cellular organization.
Outcomes depend on which ROCK-regulated cellular behavior is being examined. In smooth-muscle contexts, reduced actomyosin tension is especially relevant to contraction and vascular function. In migrating or remodeling cells, altered stress fibers and actin dynamics are more directly informative. The same intervention therefore supports different biochemical interpretations across contractile, motile, and structural systems.
An investigation can organize its readouts around the two downstream targets highlighted for ROCK: myosin light chain phosphatase and LIM kinase. It can then relate their altered phosphorylation to stress-fiber formation, actomyosin tension, and actin dynamics. This framework helps distinguish changes in contractile organization from broader effects on cell movement or shape.
Beyond basic pathway analysis, Rho kinase inhibitors support studies of vascular function, fibrosis, neuronal growth, and cancer-related motility. These applications use the same signaling connection but ask different biological questions: contractile regulation in vascular settings, tissue remodeling in fibrosis, growth behavior in neurons, or movement-associated changes in cancer. Thus, the approach spans multiple research contexts.
In biochemistry, the method is particularly informative when abnormal contractility or tissue remodeling is the central problem. Linking ROCK-dependent phosphorylation with cytoskeletal organization allows researchers to examine how molecular signaling may contribute to disease-relevant cellular behavior. Findings can also inform therapeutic strategies, although the experimental focus remains on understanding pathway control and its consequences.